Clinical Trial Update: Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abscopal effect of SBRT combined with rhGM-CSF and INF-α2b for metastatic thymic epithelial tumors is reported as ongoing with unknown …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumor

Drugs mentioned

• INF-α2b (interferon alpha-2b)
• RhGM-CSF (sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor))
• SBRT (stereotactic body radiotherapy)

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Thymic Epithelial Tumor | Phase 2 | Status: UNKNOWN